AES Corp vs BioNTech SE - ADR — how do they compare? AES Corp trades at $14.72 (market cap $10.49B), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: BioNTech SE - ADR is far larger — about 2.2× AES Corp's market cap, and AES Corp pays a 4.79% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| AES | BNTX | |
|---|---|---|
Market Cap | $10.49B | $23.31B |
Sector | Utilities | Health |
52-Week High | $17.28 | $119.34 |
52-Week Low | $12.51 | $83.89 |
Enterprise Value | $40.75B | $6.60B |
Dividend Yield | 4.79% | — |
Trailing returns across standard periods
AES is a global power company operating across 14 countries and 4 continents. Its current generation portfolio as of year-end 2021 consists of over 31 gigawatts of generation, with the generation mix composed of renewables (43%), gas (32%), coal (23%), and oil (2%). The company has 3.5 gigawatts of generation under construction. AES has majority ownership and operates six electric utilities distributing power to 2.6 million customers.
Read more on AES →BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →